Streetbeat News

Regulatory

ANAB

AnaptysBio Inc, in a recent SEC filing, announced its expectation to report approximately $417 million in cash, cash equivalents, and investments as of December 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 9:20 pm

HLTH

Cue Health announced that the FDA has decided not to prioritize the review of the company's Emergency Use Authorization (EUA) request for its product. As a result, the FDA has declined to issue an EUA at this time. Cue Health expects that payments related to the CRP will be finalized by the end of Q3 2024, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 9:19 pm

HLTH

Cue Health received a response letter from the FDA on December 28 regarding their Emergency Use Authorization (EUA) submission for a combined Flu A/B and COVID-19 molecular test, intended for over-the-counter and point-of-care use, as disclosed in an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 9:18 pm

TLLTF

VRNOF

A study in the Journal of Cancer Survivorship found that 17.4% of cancer survivors use cannabis, with many reporting symptom improvement. However, awareness of potential risks is low. The study calls for more research and education on cannabis use in cancer management. Industry players like Verano Holdings Corp. (VRNOF) and TILT Holdings Inc. (TLLTF) support breast cancer awareness initiatives.

Portfolio Pulse from Joana Scopel

January 05, 2024 | 9:15 pm

STIX

Semantix has been notified by Nasdaq that it is not in compliance with the minimum bid price requirement, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 9:14 pm

COIN

Coinbase is reportedly planning an acquisition that will enable it to offer crypto derivatives in the European Union, according to CNBC. This strategic move could potentially expand Coinbase's product offerings and market reach within the EU.

Portfolio Pulse from Charles Gross

January 05, 2024 | 9:14 pm

ABBV

AbbVie has reported in an SEC filing that its GAAP and adjusted non-GAAP earnings for Q4 will include an acquired LPR&D and milestones expense of $282 million on a pre-tax basis.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 9:12 pm

BTCUSD

ETHUSD

A Bitwise and VettaFi survey reveals 88% of financial advisors are waiting for a spot Bitcoin ETF approval to buy BTC, with only 39% expecting approval in 2024. Interest in Bitcoin among advisors dropped to 37% in 2023, while Ethereum interest increased to 25%. The report suggests crypto will become a normalized allocation, with 47% of advisors allocating more than 3% to crypto in 2023, up from 22% in 2022. Advisors also noted that clients are investing in crypto independently.

Portfolio Pulse from Khyathi Dalal

January 05, 2024 | 9:01 pm

HSCS

Heart Test Laboratories, known as HeartSciences, has received a decision to grant a European patent titled 'ELECTROCARDIOGRAM-BASED ASSESSMENT OF DIASTOLIC FUNCTION (USING MACHINE-LEARNED COMPUTATIONAL MODELS)'. This patent approval could enhance the company's intellectual property portfolio and potentially increase its market competitiveness in Europe.

Portfolio Pulse from Charles Gross

January 05, 2024 | 8:59 pm

SPY

Fed's Barkin has indicated that there is no issue with adjusting interest rates to more normal levels as confidence grows that inflation is decreasing. He suggests that the Federal Reserve should normalize rates as the economy returns to normal conditions.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 8:02 pm